Vinylbital
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
5-(1-methylbutyl)-5-vinylpyrimidine-2,4,6(1H,3H,5H)-trione | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Renal |
| Identifiers | |
| CAS Number |
2430-49-1 |
| ATC code | N05CA08 (WHO) |
| PubChem | CID 72135 |
| ChemSpider |
65109 |
| UNII |
3W58ITX06Q |
| KEGG |
D07321 |
| Chemical data | |
| Formula | C11H16N2O3 |
| Molar mass | 224.256 g/mol |
| |
| |
| | |
Vinylbital, also known as butylvinal, is a sedative hypnotic drug which is a barbiturate derivative.[1] It was developed by Aktieboleget Pharmacia in the 1950s.[2]
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
